Innovative Medicine — Percent Change (as a percent)
Johnson & Johnson Innovative Medicine — Percent Change (as a percent) increased by 3455.6% to 32.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.5%, from 22.3% to 32.0%. Over 2 years (FY 2022 to FY 2025), Innovative Medicine — Percent Change (as a percent) shows an upward trend with a 163.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Positive growth indicates expanding market share or successful product launches; negative growth suggests market saturation or competitive pressure.
Detailed definition
Calculates the period-over-period growth rate of the Innovative Medicine segment's sales. This metric normalizes perform...
Peer comparison
Standard 'Revenue Growth Rate' reported by all public companies for their business segments.
jnj_segment_innovative_medicine_percent_change_as_a_percentHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.5% | 2.5% | 2.5% | 2.5% | -33.6% | -28.8% | -48.3% | 15.7% | 18.7% | -9.2% | 22.3% | 24% | 21.3% | 0.9% | 32% |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | <-999% | +14.3% | -67.7% | +132.5% | +19.1% | -149.2% | +342.4% | +7.6% | -11.2% | -95.8% | >999% |
| YoY Change | — | — | — | — | <-999% | <-999% | — | — | +155.7% | +68.1% | +146.2% | +52.9% | +13.9% | +109.8% | +43.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's innovative medicine — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported innovative medicine — percent change (as a percent) of 32.0% in Q1 2026.
- How has Johnson & Johnson's innovative medicine — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's innovative medicine — percent change (as a percent) increased by 43.5% year-over-year, from 22.3% to 32.0%.
- What is the long-term trend for Johnson & Johnson's innovative medicine — percent change (as a percent)?
- Over 2 years (2022 to 2025), Johnson & Johnson's innovative medicine — percent change (as a percent) has grown at a 163.0% compound annual growth rate (CAGR), from 9.9% to 68.5%.
- What does innovative medicine — percent change (as a percent) mean?
- The percentage growth or decline in Innovative Medicine sales compared to the previous period.